329 related articles for article (PubMed ID: 25869733)
1. Utilizing cardiac biomarkers to detect and prevent chemotherapy-induced cardiomyopathy.
Singh D; Thakur A; Tang WH
Curr Heart Fail Rep; 2015 Jun; 12(3):255-62. PubMed ID: 25869733
[TBL] [Abstract][Full Text] [Related]
2. Role of biomarkers in chemotherapy-induced cardiotoxicity.
Cardinale D; Sandri MT
Prog Cardiovasc Dis; 2010; 53(2):121-9. PubMed ID: 20728699
[TBL] [Abstract][Full Text] [Related]
3. Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use.
Dolci A; Dominici R; Cardinale D; Sandri MT; Panteghini M
Am J Clin Pathol; 2008 Nov; 130(5):688-95. PubMed ID: 18854260
[TBL] [Abstract][Full Text] [Related]
4. [The role of biochemical markers with special regard to troponin, CK-MB, NT-proBNP as early biomarkers of cardiotoxicity among women after chemotherapy due to breast cancer].
Stachowiak P; Milchert-Leszczyńska M; Falco M; Polakowska M; Wojtarowicz A; Kaliszczak R; Safranow K; Kornacewicz-Jach Z
Przegl Lek; 2016; 73(6):359-63. PubMed ID: 29668198
[TBL] [Abstract][Full Text] [Related]
5. Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity.
Christenson ES; James T; Agrawal V; Park BH
Clin Biochem; 2015 Mar; 48(4-5):223-35. PubMed ID: 25445234
[TBL] [Abstract][Full Text] [Related]
6. [Biochemical markers for predicting chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use].
Dolci A; Dominici R; Cardinale D; Sandri MT; Panteghini M
G Ital Cardiol (Rome); 2006 Sep; 7(9):604-11. PubMed ID: 17128782
[TBL] [Abstract][Full Text] [Related]
7. The Utility of Point-of-Care Biomarkers to Detect Cardiotoxicity During Anthracycline Chemotherapy: A Feasibility Study.
Lenihan DJ; Stevens PL; Massey M; Plana JC; Araujo DM; Fanale MA; Fayad LE; Fisch MJ; Yeh ET
J Card Fail; 2016 Jun; 22(6):433-8. PubMed ID: 27079675
[TBL] [Abstract][Full Text] [Related]
8. The Role of Biomarkers in Cardio-Oncology.
Ananthan K; Lyon AR
J Cardiovasc Transl Res; 2020 Jun; 13(3):431-450. PubMed ID: 32642841
[TBL] [Abstract][Full Text] [Related]
9. Cardiotoxicity due to Chemotherapy: the Role of Biomarkers.
Stevens PL; Lenihan DJ
Curr Cardiol Rep; 2015 Jul; 17(7):603. PubMed ID: 26026994
[TBL] [Abstract][Full Text] [Related]
10. Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy.
Cardinale D; Biasillo G; Salvatici M; Sandri MT; Cipolla CM
Expert Rev Mol Diagn; 2017 Mar; 17(3):245-256. PubMed ID: 28092472
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues.
Bracun V; Aboumsallem JP; van der Meer P; de Boer RA
Curr Oncol Rep; 2020 Jun; 22(7):67. PubMed ID: 32514994
[TBL] [Abstract][Full Text] [Related]
12. Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy.
Blaes AH; Rehman A; Vock DM; Luo X; Menge M; Yee D; Missov E; Duprez D
Vasc Health Risk Manag; 2015; 11():591-4. PubMed ID: 26648730
[TBL] [Abstract][Full Text] [Related]
13. Alternative Biomarkers for Combined Biology.
Kim YH; Kirsop J; Tang WH
Heart Fail Clin; 2017 Apr; 13(2):381-401. PubMed ID: 28279423
[TBL] [Abstract][Full Text] [Related]
14. Detection and prevention of cardiac complications of cancer chemotherapy.
Monsuez JJ
Arch Cardiovasc Dis; 2012 Nov; 105(11):593-604. PubMed ID: 23177488
[TBL] [Abstract][Full Text] [Related]
15. The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature.
Mavinkurve-Groothuis AM; Kapusta L; Nir A; Groot-Loonen J
Pediatr Hematol Oncol; 2008 Sep; 25(7):655-64. PubMed ID: 18850478
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy-induced cardiotoxicity: Incidence, diagnosis and prevention].
Nelson-Veniard M; Thambo JB
Bull Cancer; 2015; 102(7-8):622-6. PubMed ID: 25935231
[TBL] [Abstract][Full Text] [Related]
17. Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers.
Akhter N; Murtagh G; Yancy C
Future Oncol; 2015; 11(14):2093-103. PubMed ID: 26198839
[TBL] [Abstract][Full Text] [Related]
18. Circulating Biomarkers for Cardiotoxicity Risk Prediction.
Gong FF; Cascino GJ; Murtagh G; Akhter N
Curr Treat Options Oncol; 2021 Apr; 22(6):46. PubMed ID: 33866434
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers as Predictors of Cardiac Toxicity From Targeted Cancer Therapies.
Witteles RM
J Card Fail; 2016 Jun; 22(6):459-64. PubMed ID: 27038641
[TBL] [Abstract][Full Text] [Related]
20. [Promote multidisciplinary study on anthracycline-induced cardiotoxicity in children].
Chen SB; Huang MR; Tang JY
Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):565-8. PubMed ID: 24225284
[No Abstract] [Full Text] [Related]
[Next] [New Search]
